Google And Eli Lilly Have Things In Common Besides Being Mutual Fund FavoritesInvestors Business Daily • 06/05/24
LLY Stock Today: How To Trade An Unbalanced Iron Condor That May Put $285 In Your PocketInvestors Business Daily • 06/03/24
Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In SpotlightInvestors Business Daily • 06/03/24
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030The Motley Fool • 06/02/24
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs saysBusiness Insider • 06/02/24
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual MeetingPRNewsWire • 06/01/24